Eduardus F. M. Posthuma

reinier de graaf hospital

H指数:18

被引数:1,027

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interim analysis of a multicenter study on patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: the RODEO study

Lokhorst, D.N.; Smit, Y.; Bemt, B.J.V.D.; Hermens, R.P.; Nijziel, M.R.; Jie, A.K.-S.; Daenen, L.G.; Klein, S.K.; Posthuma, E.F.; Westerweel, P.E.; 等. 多中心研究中期分析：慢性髓性白血病患者指导的酪氨酸激酶抑制剂剂量减少——RODEO研究. Haematologica 2026, 111, 918–926. [Google Scholar] [CrossRef]

Haematologica

IF7.9

2026-03-012

PRE

Venetoclax plus hypomethylating agents as a bridge to transplant or donor lymphocyte infusion in relapsed/refractory acute myeloid leukemia

Haematologica

IF7.9

2026-03-011

PRE

Verdeyen, Kathelijn; Reuvekamp, Tom; Van Der Velden, Walter J. F. M.; Wouters, Bas J.; Borne, Peter A. Von Dem; Van Rhenen, Anna; Lissenberg-Witte, Birgit I.; Van Lammeren, Danielle; Sluis, Geerte L. Van; De Jongh, Eva; Fiets, Roel B.; Corsten, Maarten F.; Van Der Spek, Arie C.; Gerrits, Anke M.; Van Bladel, Esther R.; Tick, Lidwine W.; De Weerdt, Okke; Van Zaane, Bregje; Cruijsen, Marjan J.; Posthuma, Eduardus F. M.; Van Elssen, Catharina H. M. J.; Klein, Saskia K.; Van De Loosdrecht, Arjan A.; De Leeuw, David C.

Clinicians’ experiences, perspectives, barriers, and facilitators of integrating palliative care into hematological malignancy care: a qualitative interview study

临床医生在将姑息治疗整合到血液学肿瘤护理中的经验、观点、障碍和促进因素：一项定性访谈研究

Supportive Care in Cancer

IF3

2025-07-180

PRE

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment

骨内弥漫性大B细胞淋巴瘤中，免疫富集肿瘤微环境与更优生存率相关。

BLOOD CANCER JOURNAL

IF11.6

2025-04-290

de Groen, Ruben A. L.; de Groot, Fleur A.; Bohringer, Stefan; Kret, Esther J.; de Haan, Lorraine M.; Noordenbos, Troy; Blommers, Susan; Jansen, Romee E. W.; van Wezel, Tom; van Eijk, Ronald; Raghoo, Richard; Ruano, Dina; Boome, Liane te; Terpstra, Valeska; Levenga, Henriette; Ahsmann, Els; Posthuma, Eduardus F. M.; Focke-Snieders, Isabelle; Hardi, Lizan; den Hartog, Wietske C. E.; van den Berg, Anke; Mutsaers, Pim; Lam, King; van der Poel, Marjolein W. M.; Hamid, Myrurgia Abdul; Woei-A-Jin, F. J. Sherida H.; Janssens, Ann; Tousseyn, Thomas; Bovee, Judith V. M. G.; Koens, Lianne; Diepstra, Arjan; Cleven, Arjen H. G.; Kersten, Marie Jose; Jansen, Patty M.; Veelken, Hendrik; Nijland, Marcel; Dekker, Tim J. A.; Vermaat, Joost S. P.

Benefits and Limitations of Real-World Patient-Reported Toxicity Symptom Monitoring for Guidelines and Care, as Perceived by Patients, Clinicians, and Guideline Developers

真实世界患者报告的毒性症状监测对指南和护理的益处与局限性，以及患者、临床医生和指南开发者的看法

CANCER MEDICINE

IF3.1

2025-04-170

OAAI

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-12-010

PRE

de Groot, Fleur A.; Dekker, Tim J. A.; Doorduijn, Jeanette K.; Bohringer, Stefan; Brink, Mirian; de Groen, Ruben A. L.; de Haan, Lorraine M.; Woei-A-Jin, F. J. Sherida H.; Noordenbos, Troy; Sijs-Szabo, Aniko; Oudshoorn, Mirjam A.; Lam, King H.; Diepstra, Arjan; te Boome, Liane C. J.; Terpstra, Valeska; Bohmer, Lara H.; Nicolae, Alina; Posthuma, Eduardus F. M.; Koens, Lianne; Durian, Marc F.; Stavast, Jeroen; van der Poel, Marjolein W. M.; Hamid, Myrurgia Abdul; Stevens, Wendy B. C.; van Rooij, Sjo L. M.; Oostvogels, Rimke S.; Muhlebner, Angelika; Neelis, Karen J.; van den Brand, Michiel; Tousseyn, Thomas; Dierickx, Daan; de Weerdt, Okke; Beeker, Aart; Jansen, Patty M.; Kersten, Marie Jose; Zijlstra, Josee M.; Chamuleau, Martine E. D.; Veelken, Hendrik; Bromberg, Jacoline C. E.; Nijland, Marcel; Vermaat, Joost S. P.

Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population-based study in the Netherlands, 1996-2020

HEMASPHERE

IF14.6

2024-11-120

OAAI

Health care utilization up to 11 years after diagnosis among patients with a hematologic malignancy and its association with socioeconomic position

JOURNAL OF CANCER SURVIVORSHIP

IF2.9

2024-09-170

PRE

Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry

ANNALS OF HEMATOLOGY

IF2.4

2024-09-160

PRE

Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21+2 R for patients with advanced-stage diffuse large B-cell lymphoma

BLOOD CANCER JOURNAL

IF11.6

2024-09-120

OAAI

Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands

BLOOD CANCER JOURNAL

IF11.6

2024-01-044

OAAI

10-day decitabine versus 3+7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3trial

LANCET HAEMATOLOGY

IF17.7

2023-11-018

PRE

Luebbert, Michael; Wijermans, Pierre W.; Kicinski, Michal; Chantepie, Sylvain; Van der Velden, Walter J. F. M.; Noppeney, Richard; Griskevicius, Laimonas; Neubauer, Andreas; Crysandt, Martina; Vrhovac, Radovan; Luppi, Mario; Fuhrmann, Stephan; Audisio, Ernesta; Candoni, Anna; Legrand, Olivier; Foa, Robin; Gaidano, Gianluca; van Lammeren-Venema, Danielle; Posthuma, Eduardus F. M.; Hoogendoorn, Mels; Giraut, Anne; Stevens-Kroef, Marian; Jansen, Joop H.; de Graaf, Aniek O.; Efficace, Fabio; Ammatuna, Emanuele; Vilque, Jean-Pierre; Waesch, Ralph; Becker, Heiko; Blijlevens, Nicole; Duehrsen, Ulrich; Baron, Frederic; Suciu, Stefan; Amadori, Sergio; Venditti, Adriano; Huls, Gerwin

Measuring chronic myeloid leukaemia TKI-related toxic effects in the real world: a systematic review and critical assessment of content validity of patient-reported outcome measures

LANCET HAEMATOLOGY

IF17.7

2023-10-011

PRE

The course of self-perceived cognitive functioning among patients with lymphoma and the co-occurrence with fatigue and psychological distress

JOURNAL OF CANCER SURVIVORSHIP

IF2.9

2023-09-273